Knowing that Chk1 is overexpressed in human B-cell lymphomas, and that the antibodies have been validated in our canine cells, we propose the use of canine B-cell lymphoma/leukemia cell lines as a model to study the role of Chk1 in canine B-cell malignancies. Here, CHEK1 is linked to leukemia.